Skip to main content

BNP Health Care Innovators

BNP Health Care Innovators is an equity fund managed by BNP Paribas in the Sektor – Helse category.

About this fund

BNP Health Care Innovators sits in the Sektor – Helse peer group, where BNP Paribas is the manager.

Jon Stephenson has managed it since 2016, 10 years.

The fund dates from 2013, giving it 13 years of history.

Tracking error against its benchmark is 6.1%.

The manager states a volatility of 15.4% for the fund.

The reference index is BM BNP Paribas Funds Health Care Innovators [14479].

Manager
BNP Paribas
Category
Sektor – Helse
Region
Global
Sector
Health Care
Style
Sector Focus
SFDR
Article 8
ISIN
LU0823416762
Inception
2013-05-17
Benchmark
BM BNP Paribas Funds Health Care Innovators [14479]
AUM
1.6 bn EUR
Returns
YTD 2.1% · 1Y 3.7% · 3Y 8.6% · 5Y 7.6%

Portfolio managers

Actively managedEquityGlobalHealth care
YTD Return · NOK
+2,1 %from NAV
Calculated NOK return from EUR · A (EUR) (NOK Calculated)

Computed from NAV history (total return, NOK, to 16 Nov 2026)

Last NAV 2 023,98 EUR · 16 Nov 2026
Returns by period · NOK · net
ann. 3Y+
+2,1 %
YTD
+3,7 %
1y
+8,6 %
3y, annualised
+7,6 %
5y, annualised
Fund size
1,6 mrd. EUR
Total fund AUM
Management fee
1,50 %
Annual · class A
Ongoing charge
1,98 %
Annual · class A
Performance fee
None
Stated by the manager
Annual cost on platforms
1,31 %–1,51 %
Class A · 5 platforms · net of platform rebate, incl. platform fee, excl. transaction costs
SFDR
Article 8
Sustainability
Launched
May 2013
ISIN LU0823416762
BenchmarkBM BNP Paribas Funds Health Care Innovators [14479]
Fund website
Risk
Volatility (stated by the manager)15,4 %
Sharpe Ratio0,61
Beta1,03
Info Ratio0,08
Tracking Error6,1 %
About the fund
The fund

BNP Health Care Innovators is an actively managed equity fund with a track record going back to 2013. The management company is BNP Paribas Asset Management, the asset management arm of the French banking group BNP Paribas. The company was expanded through the acquisition of AXA Investment Managers on 1 July 2025 and is owned by BNP Paribas Cardif.

Investment philosophy

The fund buys shares in companies worldwide that enable or benefit from innovative technologies in health care. The mandate mentions genetic sequencing, drug delivery, miniaturisation, bio-compatible materials, haptics and information technology, but is not limited to these. Selection therefore follows technology and innovation, in a growth-oriented thematic approach. ESG criteria contribute to the managers' decisions but are not decisive.

The managers

The fund is managed by a team at BNP Paribas Asset Management in Boston, with shared responsibility. Jon Stephenson has managed the fund since 2016 and is lead manager of the Health Care Innovators strategy. He came from Pioneer Investments, where he managed growth strategies, and has a background as a health care analyst at State Street Research. Christian Fay has managed the fund since 2018. He was also at BNP Paribas Asset Management in 2013–2015 before moving to Mellon, and returned in 2018. He has a background as a health care analyst at Amundi and Leerink Swann, and holds master's degrees in biology and public health as well as an MBA. Fay also manages funds such as BNP US Growth and BNP US Small Cap.

The portfolio

The selection is global and bounded by the innovation theme, not by country.

FundTelligence description · 18/10/2026
Start date not confirmed — not ranked

Portfolio managers

JO
Portfolio Manager
On the fund since May 2, 2016
CH
Portfolio Manager
On the fund since Jul 9, 2018

Fund data is taken from the managers’ own reports, otherwise computed from NAV history and, as a last resort, taken from distributor listings. Not official figures; verify with the fund provider before investing.

About our data